Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial

BACKGROUND: Angiotensin receptor blockers (ARBs), such as telmisartan, have been postulated to treat Covid-19-induced lung inflammation. METHODS: This is a parallel-group, randomized, two-arm, open-label, adaptive, multicenter superiority trial with 1:1 allocation ratio. Participants included patien...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:EClinicalMedicine
Hlavní autoři: Duarte, Mariano, Pelorosso, Facundo, Nicolosi, Liliana N., Victoria Salgado, M., Vetulli, Héctor, Aquieri, Analía, Azzato, Francisco, Castro, Marcela, Coyle, Javier, Davolos, Ignacio, Criado, Ignacio Fernandez, Gregori, Rosana, Mastrodonato, Pedro, Rubio, María C., Sarquis, Sergio, Wahlmann, Fernando, Rothlin, Rodolfo P.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8225700/
https://ncbi.nlm.nih.gov/pubmed/34189447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2021.100962
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky